GlassScriptPhysician profile
Jeffrey Scott Gruner
NPI 1073515862
$955.80
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $17.90 · 2021: $122 · 2022: $197 · 2023: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prytime Medical Devices, INC. | $230.70 | 2019-2023 | Er-Reboa Plus |
| Kci USA, INC. | $143.64 | 2019-2022 | |
| Z-Medica, LLC | $139.19 | 2019 | |
| Sanara Medtech INC. | $135.45 | 2022 | |
| Atricure, INC. | $122.30 | 2021 | |
| Becton, Dickinson and Company | $47.76 | 2023 | Phasix Mesh |
| Convatec INC. | $21.89 | 2022 | |
| Davol INC. | $21.18 | 2023 | Progel Applicator Spray Tips |
| Aroa Biosurgery Incorporated | $20.89 | 2022 | |
| Haemonetics Corporation | $19.85 | 2023 | |
| Tela Bio, INC. | $18.16 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polynovo North America LLC | $17.90 | 2020 | |
| Smith+Nephew, INC. | $16.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Gruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.